Key business figures at a glance
DSM's activities are grouped in three clusters: Nutrition, Materials and Innovation Center. We report separately on Corporate Activities. Results presented in this section (and elsewhere in this Report) relate to consolidated activities only (therefore non-consolidated partnerships are excluded).
Net sales underlying business1
|
x € million
|
2018
|
2017
|
|
Nutrition
|
5,722
|
5,579
|
|
Materials
|
2,913
|
2,825
|
|
Innovation Center
|
172
|
169
|
|
Corporate Activities
|
45
|
59
|
|
Total
|
8,852
|
8,632
|
Adjusted EBIT underlying business1
|
x € million
|
2018
|
2017
|
|
Nutrition
|
821
|
770
|
|
Materials
|
383
|
361
|
|
Innovation Center
|
(14)
|
(30)
|
|
Corporate Activities
|
(135)
|
(144)
|
|
Total
|
1,055
|
957
|
Adjusted EBITDA underlying business1
|
x € million
|
2018
|
2017
|
|
Nutrition
|
1,117
|
1,053
|
|
Materials
|
512
|
488
|
|
Innovation Center
|
8
|
9
|
|
Corporate Activities
|
(105)
|
(105)
|
|
Total
|
1,532
|
1,445
|
Adjusted EBITDA margin underlying business1
|
in %
|
2018
|
2017
|
|
Nutrition
|
19.5
|
18.9
|
|
Materials
|
17.6
|
17.3
|
|
Total
|
17.3
|
16.7
|
1 Underlying business is excluding temporary vitamin effect. See one of the tables below.
Net sales
|
x € million
|
2018
|
2017
|
|
Nutrition
|
6,137
|
5,579
|
|
Materials
|
2,913
|
2,825
|
|
Innovation Center
|
172
|
169
|
|
Corporate Activities
|
45
|
59
|
|
Total
|
9,267
|
8,632
|
Adjusted operating profit (EBIT)
|
x € million
|
2018
|
2017
|
|
Nutrition
|
1,111
|
770
|
|
Materials
|
383
|
361
|
|
Innovation Center
|
(14)
|
(30)
|
|
Corporate Activities
|
(135)
|
(144)
|
|
Total
|
1,345
|
957
|
Adjusted EBITDA
|
x € million
|
2018
|
2017
|
|
Nutrition
|
1,407
|
1,053
|
|
Materials
|
512
|
488
|
|
Innovation Center
|
8
|
9
|
|
Corporate Activities
|
(105)
|
(105)
|
|
Total
|
1,822
|
1,445
|
Adjusted EBITDA margin
|
in %
|
2018
|
2017
|
|
Nutrition
|
22.9
|
18.9
|
|
Materials
|
17.6
|
17.3
|
|
Total
|
19.7
|
16.7
|
ROCE underlying business1
|
in %
|
2018
|
2017
|
|
Nutrition
|
14.7
|
14.1
|
|
Materials
|
20.6
|
20.0
|
|
Total
|
13.3
|
12.3
|
Capital employed at 31 December
|
x € million
|
2018
|
2017
|
|
Nutrition
|
5,683
|
5,420
|
|
Materials
|
1,878
|
1,786
|
|
Innovation Center
|
597
|
562
|
|
Corporate Activities
|
23
|
(2)
|
|
Total
|
8,181
|
7,766
|
Capital expenditure
|
x € million
|
2018
|
2017
|
|
Nutrition
|
463
|
407
|
|
Materials
|
132
|
124
|
|
Innovation Center
|
32
|
43
|
|
Corporate Activities
|
26
|
12
|
|
Total, accounting based
|
653
|
586
|
|
Non-cash items
|
2
|
(39)
|
|
Customer funding
|
(9)
|
(1)
|
|
Total, cash based
|
646
|
546
|
R&D expenditure (including associated IP expenditure)
|
x € million
|
as % of net sales1
|
|||
|
2018
|
2017
|
2018
|
2017
|
|
|
Nutrition
|
206
|
219
|
3.6
|
3.9
|
|
Materials
|
122
|
130
|
4.2
|
4.6
|
|
Innovation Center
|
67
|
75
|
38.9
|
44.1
|
|
Corporate Activities
|
3
|
20
|
7.1
|
33.9
|
|
Total
|
398
|
444
|
4.5
|
5.1
|
1 Net sales from underlying business
ROCE
|
in %
|
2018
|
2017
|
|
Nutrition
|
19.9
|
14.1
|
|
Materials
|
20.6
|
20.0
|
|
Total
|
16.8
|
12.3
|
Workforce at 31 December
|
headcount
|
2018
|
2017
|
|
Nutrition
|
13,628
|
13,676
|
|
Materials
|
4,643
|
4,635
|
|
Innovation Center
|
701
|
685
|
|
Corporate Activities
|
2,005
|
2,058
|
|
Total
|
20,977
|
21,054
|
Temporary vitamin effect
|
x € million
|
Animal Nutrition & Health
|
Human Nutrition & Health
|
Total Nutrition1
|
Total
DSM2 |
|
Net sales
|
3,134
|
2,019
|
6,137
|
9,267
|
|
One-time
vitamin effect |
385
|
30
|
415
|
415
|
|
Sales from underlying business
|
2,749
|
1,989
|
5,722
|
8,852
|
|
Adjusted EBITDA
|
1,407
|
1,822
|
||
|
One-time
vitamin effect |
290
|
290
|
||
|
Adjusted EBITDA underlying business
|
1,117
|
1,532
|
1 Including other Nutrition businesses not impacted by the vitamin effect
2 Including other DSM businesses not impacted by the vitamin effect